The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...

In Q2 2025 Finland’s medicines agency, FIMEA, granted GlucoModicum authorization to initiate a new clinical investigation under Article 62 of the EU MDR (2017/745), enabling GlucoModicum to generate ...

Allspring Global Investments Holdings LLC grew its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 558.3% during the ...

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) has been given an average rating of “Moderate Buy” by the twenty-two ratings firms that are covering the stock, MarketBeat.com reports. Four research ...

For AI to be transformative in the pharmaceutical industry, it must be designed with a security-first approach. This means ...

Lifecare said on social media that it completed a significant milestone in the development of its continuous glucose monitor ...

Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required ...

If you suffered losses exceeding $100,000 in West between February 16, 2023, and February 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877 ...

Technology is making patient care more personal and easier to get, like through virtual visits. Artificial intelligence (AI) ...

Continuous glucose monitoring reveals frequent dysglycaemia in very low birth weight infants nearing term age, with male sex ...

ALC stays on investors' radar due to its Vision Care arm's performance and contributions from new products despite macro risks and stiff competition.